Evofem Biosciences, Inc. (EVFM)
OTCMKTS: EVFM · Delayed Price · USD
0.0142
-0.0007 (-4.70%)
Apr 25, 2024, 3:55 PM EDT - Market closed

Evofem Biosciences Market Cap

Evofem Biosciences has a market cap or net worth of $3.07 million as of April 26, 2024. Its market cap has decreased by -96.27% in one year.

Market Cap
3.07M
Enterprise Value
44.45M
1-Year Change
-96.27%
Ranking
n/a
Category
Stock Price
$0.01

Market Cap Chart

Since November 20, 2014, Evofem Biosciences's market cap has decreased from $159.20M to $3.07M, a decrease of -98.07%. That is a compound annual growth rate of -40.02%.

History

DateMarket Cap% Change
Aug 10, 20226.10M-22.78%
Aug 9, 20227.90M-22.55%
Aug 8, 202210.20M-15.00%
Aug 5, 202212.00M5.26%
Aug 4, 202211.40M2.70%
Aug 3, 202211.10M14.43%
Aug 2, 20229.70M-1.02%
Aug 1, 20229.80M5.38%
Jul 29, 20229.30M-1.06%
Jul 28, 20229.40M-6.00%
Jul 27, 202210.00M-4.76%
Jul 26, 202210.50M-4.55%
Jul 25, 202211.00M0.92%
Jul 22, 202210.90M-14.17%
Jul 21, 202212.70M20.95%
Jul 20, 202210.50M1.94%
Jul 19, 202210.30M-8.04%
Jul 18, 202211.20M-
Jul 15, 202211.20M-17.65%
Jul 14, 202213.60M-6.85%
Jul 13, 202214.60M-7.59%
Jul 12, 202215.80M12.06%
Jul 11, 202214.10M-18.02%
Jul 8, 202217.20M8.18%
Jul 7, 202215.90M-5.92%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 689.18B
Novo Nordisk 562.24B
UnitedHealth Group 455.31B
Johnson & Johnson 353.80B
Merck & Co. 331.07B
AbbVie 296.21B
AstraZeneca 232.58B
Thermo Fisher 218.24B
Market Cap Rankings